GO:0046470 phosphatidylcholine metabolic process: Biosynthesis, Remodeling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046470 phosphatidylcholine metabolic process describes all chemical reactions and pathways involving phosphatidylcholines, glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
• Phosphatidylcholine (PC) is a major structural constituent of eukaryotic and some bacterial membranes and a key component of lipoproteins, making its metabolism central to membrane integrity and lipid transport.
• PC can be synthesized through the CDP-choline (Kennedy) pathway and can also be generated by remodeling reactions, and its biosynthesis is closely linked to lipid droplet dynamics and lipoprotein metabolism.
• Bacterial phosphatidylcholine biosynthesis and function have been characterized, showing that PC metabolism is not restricted to eukaryotes and can be studied in microbial systems.
• PC metabolism intersects with immunity and infection: lipophagy can fuel PC synthesis for Newcastle disease virus replication, and polyene phosphatidylcholine can modulate macrophage polarization through TLR-2-mediated metabolic reprogramming.
• Alterations in PC metabolism are detectable in human disease contexts such as gastric carcinogenesis and metabolic associated fatty liver disease, supporting its value as a research and biomarker target.
Description
Phosphatidylcholine metabolic process (GO:0046470) is the biological process comprising the chemical reactions and pathways involving phosphatidylcholines, a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline. These molecules are important constituents of cell membranes, and their metabolism is therefore fundamental to membrane biogenesis, lipid signaling, and lipid transport. Because phosphatidylcholines are also core components of lipoproteins, the process is mechanistically tied to lipoprotein metabolism and systemic lipid handling. Researchers study GO:0046470 to understand how cells build and remodel membranes, how lipids are packaged and secreted, and how these pathways are rewired in disease. The process is experimentally tractable across systems. In bacteria, phosphatidylcholine biosynthesis and function have been genetically and biochemically dissected, providing a comparative framework for the pathway. In eukaryotes, phosphatidylcholine metabolism is dynamically connected to lipid droplets and to the storage and mobilization of neutral lipids. Recent work shows that lipophagy can supply substrates for phosphatidylcholine synthesis during viral infection, linking autophagic lipid catabolism to membrane lipid production. Clinically, phosphatidylcholine metabolism is relevant to metabolic and neoplastic disease. Integrative metabolomics and microbiomics have identified distinctive microbiota-metabolite interactions involving phosphatidylcholine-related metabolites in gastric carcinogenesis. Polyene phosphatidylcholine has been studied for its clinical efficacy and mechanism in metabolic associated fatty liver disease, including in combination with atorvastatin. In immunology, polyene phosphatidylcholine can inhibit M1 macrophage polarization via TLR-2-mediated metabolic reprogramming, illustrating how PC-related metabolism shapes inflammatory cell states. Together, these findings make GO:0046470 a high-value term for mechanistic, translational, and CRISPR-based research.
phosphatidylcholine metabolic process At A Glance
| GO ID | GO:0046470 |
|---|---|
| GO term | phosphatidylcholine metabolic process |
| Ontology | biological_process |
| Synonym | phosphatidylcholine metabolism |
| Definition | The chemical reactions and pathways involving phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline. They are important constituents of cell membranes. |
| Major function | Production, remodeling, and turnover of phosphatidylcholine for membrane assembly, lipoprotein metabolism, and lipid signaling |
| Related lipids | Glycerophospholipids and choline-containing phospholipids |
| Cellular context | Membranes, lipid droplets, and lipoprotein particles |
| Disease relevance | Metabolic associated fatty liver disease, gastric carcinogenesis, and infection/immunity-related metabolic reprogramming |
What Is GO:0046470?
In this article, phosphatidylcholine metabolic process (GO:0046470) refers to the chemical reactions and pathways involving phosphatidylcholines, which are glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline; these lipids are important constituents of cell membranes. The term covers both the construction of phosphatidylcholine molecules and the reactions that modify, interconvert, or turnover them within cellular metabolism.
Why Is phosphatidylcholine metabolic process Important in Cell Biology?
Phosphatidylcholine metabolic process matters because phosphatidylcholines are essential membrane glycerophospholipids and core components of lipoproteins, so the pathways that make and remodel them directly influence membrane integrity, lipid transport, and cellular lipid homeostasis. The process is also integrated with lipid droplet biology, meaning it sits at the interface of energy storage and membrane biogenesis. Its importance extends to host-pathogen interactions, since lipophagy can fuel phosphatidylcholine synthesis to support viral replication, and to immunometabolism, where polyene phosphatidylcholine modulates macrophage polarization through TLR-2-mediated metabolic reprogramming. In human disease, phosphatidylcholine-related metabolites have been linked to gastric carcinogenesis, and polyene phosphatidylcholine has been evaluated clinically and mechanistically in metabolic associated fatty liver disease. Finally, bacterial phosphatidylcholine biosynthesis and function demonstrate that this process is evolutionarily widespread and experimentally accessible.
• Provides the membrane phospholipid phosphatidylcholine, an important constituent of cell membranes.
• Supports lipoprotein metabolism because phosphatidylcholine is a key component of lipoproteins.
• Connects to lipid droplet dynamics and neutral lipid storage.
• Can be fueled by lipophagy during infection, supporting Newcastle disease virus replication.
• Participates in immunometabolic control, including TLR-2-mediated inhibition of M1 macrophage polarization by polyene phosphatidylcholine.
• Is detectable through metabolomic and microbiomic signatures in gastric carcinogenesis.
• Is a therapeutic and mechanistic focus in metabolic associated fatty liver disease, including polyene phosphatidylcholine plus atorvastatin.
• Is conserved in bacteria, enabling comparative genetic studies of phosphatidylcholine biosynthesis and function.
• Can be monitored biophysically, for example by SERS analysis of phosphatidylcholine oxidation.
• Offers a rich target space for CRISPR knockout, knock-in, and overexpression studies of lipid metabolic genes.
What Happens During phosphatidylcholine metabolic process?
Phosphatidylcholine biosynthesis and the CDP-choline pathway
In simple terms: Cells build phosphatidylcholine by attaching choline-containing building blocks to a lipid backbone.
Phosphatidylcholine biosynthesis is a central arm of GO:0046470 and has been reviewed in the context of lipoprotein metabolism, where the pathway supplies phosphatidylcholine for membrane and lipoprotein assembly. In bacteria, phosphatidylcholine biosynthesis and function have also been characterized, showing that distinct enzymatic routes can produce this phospholipid outside of the canonical eukaryotic setting. The process is therefore defined by the enzymatic conversion of precursors into phosphatidylcholine and by the subsequent use of the product in membranes and lipoproteins.
Remodeling and turnover of phosphatidylcholine
In simple terms: After it is made, phosphatidylcholine can be chemically edited and recycled.
Phosphatidylcholine metabolic process includes reactions that modify and turn over existing phosphatidylcholine molecules, not only de novo synthesis. This remodeling capacity allows cells to adjust membrane lipid composition and to respond to metabolic demand. The dynamic nature of the process is also reflected in its relationship to lipid droplets, which are intracellular sites where lipid storage and mobilization intersect with phospholipid metabolism.
Lipophagy as a substrate source for phosphatidylcholine synthesis
In simple terms: Cells can digest their own lipid stores to obtain material for making phosphatidylcholine.
Lipophagy, the autophagic degradation of lipid droplets, can fuel phosphatidylcholine synthesis, and this supply route supports Newcastle disease virus replication. This finding places GO:0046470 downstream of autophagic lipid catabolism and demonstrates that phosphatidylcholine production can be sustained by recycled lipid substrates during infection. It also connects the process to lipid droplet biology, since lipid droplets are the storage organelles mobilized in this context.
Oxidation and biophysical monitoring of phosphatidylcholine
In simple terms: Phosphatidylcholine can be oxidized, and this chemical change can be measured.
The oxidation process of phosphatidylcholine has been dynamically monitored using surface-enhanced Raman scattering (SERS) analysis, providing a biophysical readout of phosphatidylcholine chemical change. Such measurements are relevant to GO:0046470 because oxidation alters the chemical state of phosphatidylcholine and can be used to track its metabolic and oxidative fate in experimental systems.
Phosphatidylcholine metabolism in immunometabolic reprogramming
In simple terms: Phosphatidylcholine-related metabolism can change how immune cells behave.
Polyene phosphatidylcholine can inhibit M1 macrophage polarization through TLR-2-mediated metabolic reprogramming, showing that phosphatidylcholine-related metabolism participates in immune cell state transitions. This links GO:0046470 to inflammatory signaling and to the metabolic control of macrophage function. It also illustrates how pharmacological or nutritional modulation of phosphatidylcholine metabolism can have immunomodulatory consequences.
Key Genes Involved in GO:0046470 phosphatidylcholine metabolic process
The following genes and proteins are representative molecular players and research entry points associated with phosphatidylcholine metabolic process (GO:0046470) and its experimental study.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHKA | Choline kinase activity in phosphatidylcholine biosynthesis | Candidate for knockout and metabolic flux studies of PC synthesis |
| CHKB | Choline kinase isoform contributing to choline phosphorylation | Model for isoform-specific PC pathway dissection |
| PCYT1A | CTP:phosphocholine cytidylyltransferase in the CDP-choline pathway | Rate-controlling node for PC biosynthesis and membrane demand |
| PCYT1B | CTP:phosphocholine cytidylyltransferase isoform | Isoform-specific regulation of PC synthesis |
| CHPT1 | Diacylglycerol cholinephosphotransferase in PC synthesis | Enzymatic step for de novo PC production |
| CEPT1 | Choline/ethanolamine phosphotransferase in phospholipid synthesis | Intersection of PC and PE pathways |
| PLA2G4A | Phospholipase A2-type activity that can remodel PC | Remodeling and arachidonic acid release studies |
| LPCAT1 | Lysophosphatidylcholine acyltransferase in PC remodeling | Lands acyl chains to generate mature PC |
| LPCAT2 | Lysophosphatidylcholine acyltransferase isoform | Inflammatory and remodeling context |
| PEMT | Phosphatidylethanolamine N-methyltransferase producing PC | Alternative PC synthesis route in liver |
| PLD1 | Phospholipase D activity linked to phosphatidylcholine turnover | Signaling and membrane lipid turnover |
| PLD2 | Phospholipase D isoform linked to PC metabolism | Membrane remodeling and signaling |
| ABCA1 | Lipid transporter in lipoprotein metabolism | PC availability for lipoprotein assembly |
| APOA1 | Apolipoprotein component of HDL | PC-dependent lipoprotein biology |
| APOB | Apolipoprotein component of VLDL/LDL | PC-dependent lipoprotein secretion |
| MTOR | Central metabolic regulator influencing lipid synthesis | Upstream control of anabolic lipid metabolism |
| TLR2 | Innate immune receptor in metabolic reprogramming | Polyene phosphatidylcholine effects on macrophages |
| MAP1LC3B | Autophagy-related protein in lipophagy | Lipophagy-driven PC synthesis during infection |
How Is phosphatidylcholine metabolic process Regulated?
Phosphatidylcholine metabolic process is regulated at the level of pathway demand and substrate supply. Because phosphatidylcholine is required for membrane and lipoprotein assembly, its biosynthesis is coordinated with lipoprotein metabolism. Lipid droplets serve as dynamic lipid storage sites that intersect with phospholipid metabolism, providing a regulatory interface between storage and membrane lipid production. Lipophagy can supply substrates for phosphatidylcholine synthesis, adding an autophagic control layer that is exploited during Newcastle disease virus replication. In immune cells, TLR-2-mediated metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization, indicating that innate immune signaling can reshape phosphatidylcholine-related metabolism. These layers of regulation make GO:0046470 responsive to nutritional, infectious, and inflammatory cues.
phosphatidylcholine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PEMT | Hepatic phosphatidylcholine synthesis and fatty liver biology | Liver-specific knockout or overexpression in hepatocyte models |
| TLR2 | Macrophage polarization and immunometabolism | TLR2 knockout macrophages treated with polyene phosphatidylcholine |
| MAP1LC3B | Lipophagy-dependent phosphatidylcholine synthesis during viral infection | Knockout or knockdown in infection models |
| ABCA1 | Lipoprotein metabolism and cholesterol efflux | Knockout and knock-in in lipid transport studies |
| CHKA | Phosphatidylcholine biosynthetic flux in cancer metabolism | CRISPR knockout with metabolomic profiling |
Phosphatidylcholine metabolism in metabolic associated fatty liver disease
Polyene phosphatidylcholine has been studied for clinical efficacy and mechanism in metabolic associated fatty liver disease, including in combination with atorvastatin. This places phosphatidylcholine-related metabolism within the pathophysiology and treatment landscape of fatty liver disease. Because phosphatidylcholine is required for lipoprotein metabolism, perturbations in its metabolic process can influence hepatic lipid handling.
Phosphatidylcholine-related metabolites in gastric carcinogenesis
Integrative metabolomics and microbiomics analysis has revealed distinctive microbiota-metabolite interactions in gastric carcinogenesis, including phosphatidylcholine-related metabolic signatures. These findings support the use of phosphatidylcholine metabolism as a component of metabolic profiling in cancer research. The connection between microbial communities and lipid metabolites further suggests that GO:0046470 can be studied in the context of host-microbiome interactions.
Phosphatidylcholine metabolism in infection and immunity
Lipophagy fuels phosphatidylcholine synthesis for Newcastle disease virus replication, directly linking GO:0046470 to viral infection. In parallel, polyene phosphatidylcholine can inhibit M1 macrophage polarization through TLR-2-mediated metabolic reprogramming, linking phosphatidylcholine-related metabolism to innate immune cell function. Together, these studies show that phosphatidylcholine metabolism can be proviral or immunomodulatory depending on context.
Oxidative modification of phosphatidylcholine
The oxidation process of phosphatidylcholine can be dynamically monitored using SERS analysis, providing a method to detect oxidative changes in this lipid class. Oxidative modification is relevant to disease because it alters the chemical state of phosphatidylcholine and can be measured as a readout of lipid stress. This makes oxidation monitoring a useful adjunct to studies of GO:0046470 in disease models.
From phosphatidylcholine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a PC biosynthetic enzyme alter membrane lipid composition? | CRISPR knockout cell model with lipidomics readout |
| Does a disease-associated point mutation change PC pathway flux? | Point-mutation knock-in cell model |
| Can a tagged PC enzyme be tracked in live cells? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of a PC synthesis gene increase lipoprotein output? | Overexpression cell model with lipoprotein assays |
| Does lipophagy contribute to PC synthesis during infection? | Knockout of autophagy genes plus infection challenge |
| Does TLR-2 signaling mediate PC-dependent macrophage polarization? | TLR2 knockout or overexpression in macrophage models |
How to Study the phosphatidylcholine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics | Phosphatidylcholine species and related lipids | Quantifying PC pathway output in edited cells |
| Metabolomics | Small-molecule metabolites including choline-containing compounds | Pathway flux and biomarker discovery |
| SERS analysis | Oxidation state of phosphatidylcholine | Dynamic monitoring of PC oxidation |
| Lipoprotein assays | Lipoprotein assembly and secretion | Testing PC-dependent lipid transport |
| Viral replication assays | Pathogen replication in edited cells | Testing lipophagy-fueled PC synthesis |
| Macrophage polarization assays | M1/M2 marker expression | Testing PC-mediated immunometabolic effects |
| Bacterial genetics | PC biosynthesis and function in bacteria | Comparative pathway studies |
| Lipid droplet imaging | Lipid droplet number and size | Linking PC metabolism to storage organelles |
Lipidomics and metabolomics
Lipidomics and metabolomics can quantify phosphatidylcholine species and related metabolites, providing a direct readout of GO:0046470 activity. Integrative metabolomics and microbiomics has been used to identify phosphatidylcholine-related metabolic signatures in gastric carcinogenesis, demonstrating the utility of multi-omic profiling. These methods are well suited to comparing CRISPR knockout or overexpression models of phosphatidylcholine metabolic genes.
SERS-based oxidation monitoring
Surface-enhanced Raman scattering (SERS) analysis enables dynamic monitoring of the oxidation process of phosphatidylcholine. This approach measures chemical changes in the phosphatidylcholine molecule and can be applied to track oxidative modification in experimental samples. It complements mass-spectrometry-based lipidomics by providing a biophysical readout of lipid oxidation state.
Lipoprotein and lipid transport assays
Because phosphatidylcholine biosynthesis is linked to lipoprotein metabolism, lipoprotein and lipid transport assays are informative for GO:0046470. Such assays can measure how changes in phosphatidylcholine synthesis affect lipoprotein assembly and secretion. They are particularly relevant when studying genes such as ABCA1, APOA1, and APOB in CRISPR-edited cells.
Infection and immunometabolism assays
Infection models can test whether lipophagy-derived phosphatidylcholine supports viral replication, as shown for Newcastle disease virus. Macrophage polarization assays can test whether polyene phosphatidylcholine modulates M1 polarization through TLR-2-mediated metabolic reprogramming. Combining these functional assays with CRISPR editing allows causal testing of phosphatidylcholine metabolic genes in infection and immunity.
How CRISPR Can Be Used to Study GO:0046470 phosphatidylcholine metabolic process
Knockout
CRISPR knockout of phosphatidylcholine metabolic genes such as CHKA, PCYT1A, or PEMT can test whether loss of a specific enzymatic step alters phosphatidylcholine levels and downstream membrane or lipoprotein phenotypes. Knockout models are also useful for testing lipophagy-dependent phosphatidylcholine synthesis during infection by targeting autophagy-related genes. In immunometabolism, knockout of TLR2 can test whether TLR-2 signaling is required for polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization.
Point Mutation
Point-mutation knock-in can model disease-associated or catalytically important residues in phosphatidylcholine metabolic enzymes, allowing researchers to separate catalytic activity from scaffolding functions. Such models are valuable when a variant is suspected to alter pathway flux without abolishing protein expression. Point-mutation models can be combined with lipidomics to quantify effects on phosphatidylcholine species.
Knock-in
Knock-in of tags or reporters into phosphatidylcholine metabolic genes enables tracking of enzyme localization and dynamics in living cells. Tagged knock-in models can reveal whether enzymes localize to membranes, lipid droplets, or other compartments relevant to phosphatidylcholine metabolism. Knock-in of regulatory elements can also be used to study pathway control under metabolic stress.
Overexpression
Overexpression of phosphatidylcholine biosynthetic genes can test sufficiency for increased phosphatidylcholine production and lipoprotein output. Overexpression models are also useful for studying whether increased phosphatidylcholine synthesis supports viral replication or alters macrophage polarization. Combining overexpression with metabolomics provides a direct readout of pathway activation.
How EDITGENE Supports phosphatidylcholine metabolic process Research
Researchers studying phosphatidylcholine metabolic process-related genes often need to determine whether a candidate gene is causally involved in phosphatidylcholine production, remodeling, or downstream membrane and lipoprotein phenotypes. EDITGENE provides CRISPR-based cell model services that allow precise, reproducible perturbation of these genes in relevant cellular backgrounds.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylcholine metabolic process research.
Frequently Asked Questions About phosphatidylcholine metabolic process
What is phosphatidylcholine metabolic process?
Phosphatidylcholine metabolic process (GO:0046470) is the biological process comprising the chemical reactions and pathways involving phosphatidylcholines, glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline; they are important constituents of cell membranes.
What is the GO ID for phosphatidylcholine metabolic process?
The GO ID is GO:0046470, and the official term is phosphatidylcholine metabolic process.
What genes are involved in phosphatidylcholine metabolic process?
Genes involved include CHKA, CHKB, PCYT1A, PCYT1B, CHPT1, CEPT1, LPCAT1, LPCAT2, PEMT, PLD1, PLD2, ABCA1, APOA1, APOB, TLR2, and MAP1LC3B, based on their roles in phosphatidylcholine synthesis, remodeling, lipoprotein metabolism, and related pathways.
Why is phosphatidylcholine important for cell membranes?
Phosphatidylcholines are important constituents of cell membranes, and their metabolism supplies and maintains membrane phospholipid content.
How is phosphatidylcholine linked to lipoprotein metabolism?
Phosphatidylcholine biosynthesis and lipoprotein metabolism are mechanistically linked because phosphatidylcholine is a key component of lipoproteins.
Can phosphatidylcholine metabolism be studied with CRISPR?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models can be used to perturb phosphatidylcholine metabolic genes and measure downstream lipid and membrane phenotypes.
What diseases are associated with phosphatidylcholine metabolism?
Phosphatidylcholine-related metabolism has been associated with metabolic associated fatty liver disease, gastric carcinogenesis, and infection/immunity contexts such as Newcastle disease virus replication and macrophage polarization.
How is phosphatidylcholine oxidation measured?
Phosphatidylcholine oxidation can be dynamically monitored using surface-enhanced Raman scattering (SERS) analysis.
Does lipophagy affect phosphatidylcholine synthesis?
Yes, lipophagy can fuel phosphatidylcholine synthesis, and this process supports Newcastle disease virus replication.
Is phosphatidylcholine metabolism present in bacteria?
Yes, phosphatidylcholine biosynthesis and function have been characterized in bacteria, showing that this process is not limited to eukaryotes.
Conclusion
Phosphatidylcholine metabolic process (GO:0046470) is a central lipid metabolic pathway that produces and remodels phosphatidylcholine, an important membrane glycerophospholipid and a key component of lipoproteins. Its study spans membrane biology, lipid droplet dynamics, lipoprotein metabolism, infection, and immunometabolism, with experimental evidence linking it to viral replication, macrophage polarization, gastric carcinogenesis, and fatty liver disease. Bacterial phosphatidylcholine biosynthesis further highlights the evolutionary breadth of the process. For researchers, GO:0046470 offers a tractable and translationally relevant target space. CRISPR knockout, point-mutation, knock-in, and overexpression models, combined with lipidomics, metabolomics, SERS oxidation monitoring, and functional infection or immune assays, can define causal roles for phosphatidylcholine metabolic genes. EDITGENE supports these efforts with end-to-end cell model generation, library screening, and bioinformatics services.
References
- 1. Xiang S et al.. 2018. Dynamic Monitoring of the Oxidation Process of Phosphatidylcholine Using SERS Analysis.. Anal Chem 90(22):13751-13758 PMID: 30350609
- 2. Penno A et al.. 2013. Phospholipids and lipid droplets.. Biochim Biophys Acta 1831(3):589-94 PMID: 23246574
- 3. Yang M et al.. 2026. Lipophagy fuels phosphatidylcholine synthesis for Newcastle disease virus replication.. Autophagy 22(6):1351-1368 PMID: 41810751
- 4. Jiang XW et al.. 2025. Integrative metabolomics and microbiomics analysis reveals distinctive microbiota-metabolites interactions in gastric carcinogenesis.. Int J Cancer 156(12):2389-2400 PMID: 40065492
- 5. Feng TT et al.. 2020. TLR-2-mediated metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization.. Immunol Res 68(1):28-38 PMID: 32248343
- 6. Cole LK et al.. 2012. Phosphatidylcholine biosynthesis and lipoprotein metabolism.. Biochim Biophys Acta 1821(5):754-61 PMID: 21979151
- 7. Cheng C et al.. 2026. Clinical efficacy and mechanism of polyene phosphatidylcholine combined with atorvastatin in treating metabolic associated fatty liver disease.. Pak J Pharm Sci 39(2):415-420 PMID: 41546577
- 8. Geiger O et al.. 2013. Phosphatidylcholine biosynthesis and function in bacteria.. Biochim Biophys Acta 1831(3):503-13 PMID: 22922101
